HAL stock hit a new 52-week high of Rs 3,078.8 in today’s trade after brokerage UBS initiated coverage on the stock with Buy rating and target price of Rs 3,600.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale